Article
Identification of an unusual combination of actionable mutations through genomic profiling in a child with an aggressive sarcoma.
2023-09-19
Abstract excerpt
Rhabdomyosarcoma (RMS) is a highly aggressive pediatric cancer known for its therapeutic challenges, particularly when it becomes metastatic or recurrent. Traditional treatment approaches have shown limited success, prompting a growing interest in targeted therapies. The emergence of next-generation sequencing (NGS) has revolutionized our ability to identify actionable mutations in RMS, offering the promise of per...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0d867526-e35b-52be-8046-4d33b7bf2b12
- DOI
- 10.22541/au.169513402.26701421/v1
